Larosa Joseph J

Avg. Two Year Performance

No purchase track record
3% Avg. Sale Return
2% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(1%)(8%)(9%)5%3%
Sale Success Rate1 of 61 of 61 of 61 of 61 of 6

Regeneron Pharmaceuticals I...

Drugs » Biotechnology

EVP General Counsel and Secret:

Holdings: 40.27K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--